FMR LLC grew its position in BrightSpring Health Services, Inc. (NASDAQ:BTSG - Free Report) by 21.6% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 22,102,490 shares of the company's stock after acquiring an additional 3,933,303 shares during the quarter. FMR LLC owned about 12.69% of BrightSpring Health Services worth $376,405,000 at the end of the most recent reporting period.
Several other institutional investors also recently bought and sold shares of BTSG. BNP Paribas Financial Markets grew its stake in BrightSpring Health Services by 5.0% in the 3rd quarter. BNP Paribas Financial Markets now owns 21,329 shares of the company's stock valued at $313,000 after acquiring an additional 1,011 shares during the last quarter. Rhumbline Advisers lifted its holdings in shares of BrightSpring Health Services by 1.5% during the 4th quarter. Rhumbline Advisers now owns 73,583 shares of the company's stock valued at $1,253,000 after acquiring an additional 1,118 shares in the last quarter. R Squared Ltd acquired a new position in BrightSpring Health Services in the 4th quarter worth $74,000. Charles Schwab Investment Management Inc. increased its holdings in BrightSpring Health Services by 1.5% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 440,335 shares of the company's stock worth $6,464,000 after purchasing an additional 6,326 shares during the last quarter. Finally, Geode Capital Management LLC raised its stake in shares of BrightSpring Health Services by 0.5% in the 4th quarter. Geode Capital Management LLC now owns 1,311,204 shares of the company's stock valued at $22,335,000 after purchasing an additional 6,990 shares in the last quarter.
Analyst Upgrades and Downgrades
A number of research analysts have issued reports on BTSG shares. Morgan Stanley boosted their target price on shares of BrightSpring Health Services from $19.00 to $20.00 and gave the company an "overweight" rating in a research note on Tuesday, December 17th. UBS Group raised their price target on shares of BrightSpring Health Services from $22.00 to $30.00 and gave the stock a "buy" rating in a report on Wednesday, January 29th. One analyst has rated the stock with a hold rating and nine have assigned a buy rating to the company. Based on data from MarketBeat, BrightSpring Health Services currently has a consensus rating of "Moderate Buy" and an average target price of $21.67.
View Our Latest Stock Analysis on BrightSpring Health Services
BrightSpring Health Services Stock Performance
BrightSpring Health Services stock traded up $0.04 during mid-day trading on Wednesday, hitting $17.12. 193,325 shares of the company's stock traded hands, compared to its average volume of 1,276,607. The stock has a market cap of $3.00 billion, a price-to-earnings ratio of -65.92 and a beta of 2.02. The firm has a 50 day simple moving average of $18.69 and a two-hundred day simple moving average of $18.31. The company has a debt-to-equity ratio of 1.63, a current ratio of 1.35 and a quick ratio of 0.97. BrightSpring Health Services, Inc. has a fifty-two week low of $10.15 and a fifty-two week high of $24.82.
BrightSpring Health Services Company Profile
(
Free Report)
BrightSpring Health Services, Inc operates a home and community-based healthcare services platform in the United States. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations.
Featured Stories

Before you consider BrightSpring Health Services, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and BrightSpring Health Services wasn't on the list.
While BrightSpring Health Services currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering when you'll finally be able to invest in SpaceX, Starlink, or X.AI? Enter your email address to learn when Elon Musk will let these companies finally IPO.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.